SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing a significant sell-off as investors react to a large equity offering intended to fund increased hardware costs for a substantial backlog of AI server orders. The community is heavily divided, with some investors viewing the dilution as a necessary step to support long-term growth and others expressing frustration over management transparency, historical accounting concerns, and the immediate negative impact on share price.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing heightened volatility as investors weigh a record AI infrastructure backlog against concerns over debt and capital expenditure ahead of upcoming earnings. While the community remains divided between those viewing the pullback as a buying opportunity and others bracing for a broader sell-off, high options volume suggests significant anticipation for how the company's cloud demand translates into bottom-line growth.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the community debate the company's valuation amid ongoing market volatility and controversies surrounding the administration. Online discourse is heavily focused on the geopolitical impact of the escalating Iran conflict, rising inflation concerns, and aggressive political polarization regarding the president's policy decisions.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

Fubo is experiencing a surge in trading volume and positive price momentum following the news that NBCUniversal channels are returning to the platform. Investors are actively debating the long-term impact of this carriage deal, with many pointing to the upcoming World Cup as a potential catalyst for subscriber growth while others remain skeptical due to past performance and management track record.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending due to heightened selling pressure as the ETF trades below its 200-day moving average, fueling debate over whether the asset can maintain its historical status as an inflation hedge amid a strong dollar and rising bond yields. Market participants are actively discussing potential support levels, debating the impact of geopolitical escalations, and questioning if current price action represents a buying opportunity or a deeper structural reset.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is experiencing heightened volatility and significant selling pressure as investors weigh concerns about sector-wide weakness and ongoing dilution against the company's aggressive acquisition strategy. The community is sharply divided, with some investors aggressively averaging down based on confidence in the CEO's long-term track record, while others express frustration over the stock's persistent decline and the risks associated with the upcoming TopBuild merger.

Cartesian Growth Corp III is a blank-check company that is sponsored by Cartesian Capital Group LLC. The company aims to acquire or merge with an established, high-growth business seeking access to public markets and capital. The company provides financial and operational expertise post-combination.

Factorial Energy Inc. - Ordinary Shares- Class A

Factorial Energy is trending as traders speculate on the company's solid-state battery technology and high-profile automotive partnerships, driving significant volatility and interest in its low-float structure. Community discussion is focused on the potential for parabolic moves, with many users debating the sustainability of the price swings and comparing its market setup to other recent high-momentum SPACs.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is generating significant investor chatter as the community debates the company's progress toward commercialization and FAA certification milestones amidst ongoing institutional selling. Discussions are heavily polarized, pitting retail investors optimistic about the stock's future role in urban air mobility against skeptics who are scrutinizing the company's lack of piloted transition flights and the long-term impact of recent institutional divestments.

Cracker Barrel Old Country Store, Inc. engages in the operation and development of restaurant and retail outlets. The format of its stores consists of a trademarked rustic old country-store design that offers restaurant menu featuring home-style country food. The company was founded by Dan W. Evins on September 19, 1969 and is headquartered in Lebanon, TN.

Cracker Barrel Old Country Store Inc

Cracker Barrel is trending due to a significant earnings beat and raised guidance that triggered a sharp short squeeze, with the community intensely debating whether this momentum is a sustainable turnaround or a temporary trap fueled by retail liquidity. While some investors are betting on further upside potential and positive execution, others are highlighting the company's reliance on litigation settlements to bolster net income, leading to cautious perspectives on the stock's long-term health.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is experiencing extreme volatility and intense community discussion following a dramatic decline triggered by an indictment involving co-founders in alleged export violations. Investors are debating the risks of holding a 2x leveraged ETF through such turbulence, while others are aggressively seeking entry points as they speculate on a potential short squeeze or recovery.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: Alzamend Neuro (NASDAQ:ALZN) Director Buys 108,388 Shares of Stock

Alzamend Neuro, Inc. (NASDAQ:ALZN - Get Free Report) Director Milton Ault III bought 108,388 shares of the stock in a transaction dated Tuesday, April 14th. The shares were purchased at an average price of $1.00 per share, for a total transaction of $108,388.00. Following the purchase, the director...

Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital

Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 'Lithium in Brain' Study in a Trial Conducted at Massachusetts General Hospital Alzamend Neuro Reports...

Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions

Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001...

Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital

Alzamend Neuro Initiates Phase II Clinical Trial of AL001 'Lithium in Brain' Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital Alzamend Neuro Initiates...

Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?

Here is how Allogene Therapeutics (ALLO) and Alzamend Neuro, Inc. (ALZN) have performed compared to their sector so far this year.

Is AIM ImmunoTech (AIM) Stock Outpacing Its Medical Peers This Year?

Here is how AIM ImmunoTech Inc. (AIM) and Alzamend Neuro, Inc. (ALZN) have performed compared to their sector so far this year.

EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth?

Embecta's Q4 earnings loom as product momentum, global trends and recent strategic gains set the stage for potential top-line support.

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 'Lithium in Brain' Study Conducted at Massachusetts General Hospital Alzamend Neuro Announces Completion of...

EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants

Alzamend Neuro completed its first Phase 2 trial for AL001, a novel lithium therapy aiming for better brain delivery and safety, reducing the need for drug monitoring.read more...

Alzamend Neuro Stock Rockets On Dosing Of First Human Patient With Lithium-Delivery System AL001 In Phase II Study: Retail’s Thrilled

Equity

AL001 has the potential to provide the benefits of marketed lithium salts while mitigating currently experienced toxicities associated with lithium.

Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Atlanta, GA.

ALZNAlzamend Neuro Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALZN News